loading

Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
71.33%
2.17
7.57 9.018 4.475 55.13
Operating Expenses
1.86%
287.09
292.54 283.40 346.19 285.70
Benefits Costs and Expenses
28.87%
271.43
210.62 243.53 228.86 -15.01
Costs And Expenses
28.87%
271.43
210.62 243.53 228.86 -15.01
Operating Income/Loss
0.02%
-284.92
-284.96 -274.38 -341.71 -120.19
Income/Loss From Continuing Operations Before Tax
32.61%
-269.26
-203.05 -234.51 -224.38 70.14
Income Tax Expense/Benefit
90.57%
4.649
49.32 -25.57 12.46 12.65
Income/Loss From Continuing Operations After Tax
8.53%
-273.91
-252.38 -208.94 -236.84 57.49
Income/Loss From Discontinued Operations, Net Of Tax
-
- 327.02 -43.08 89.09
Net Income/Loss
8.53%
-273.91
-252.38 118.08 -279.92 57.49
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
10.14%
-50.56
-45.90 -51.31 -49.74 -37.81
Basic Average Shares
11,586%
680.29
-5.9226 722.72 735.47 735.82
Diluted Average Shares
11,586%
680.29
-5.9226 722.72 735.47 781.63
Basic Earnings Per Share
13.79%
-0.33
-0.29 0.23 -0.31 0.13
Diluted Earnings Per Share
13.79%
-0.33
-0.29 0.23 -0.31 0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):